Loading...
XSHE
300244
Market cap1.69bUSD
Jul 10, Last price  
20.46CNY
1D
11.56%
1Q
9.12%
Jan 2017
-36.06%
IPO
397.78%
Name

Dian Diagnostics Group Co Ltd

Chart & Performance

D1W1MN
XSHE:300244 chart
P/E
290.27
P/S
1.27
EPS
0.07
Div Yield, %
1.36%
Shrs. gr., 5y
-0.31%
Rev. gr., 5y
-1.06%
Revenues
10.10b
-17.22%
178,290,078263,253,242343,273,048482,474,271706,418,7231,015,474,4361,335,100,1441,858,180,8883,823,980,6235,004,124,1786,966,857,3668,453,207,04610,649,161,77213,082,613,19920,282,469,25813,408,319,79812,196,223,73310,096,031,634
Net income
44m
P
6,589,69117,168,78732,411,25642,208,33160,187,69886,093,297124,584,451174,794,717262,760,910349,592,991388,608,438347,281,821802,932,5541,162,884,3541,434,191,157307,461,066-357,277,64544,052,664
CFO
2.03b
+67.99%
04,056,35441,225,46220,204,16825,656,07375,438,947117,949,327131,286,595132,247,09438,510,798373,237,375483,185,6271,547,226,9921,317,918,1471,639,364,9921,921,354,0061,207,395,6482,028,332,871
Dividend
Jun 18, 20250.25 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dian Diagnostics Group Co.,Ltd. operates as a leading independent provider of medical diagnostic services within China. The company delivers comprehensive diagnostic solutions to a broad spectrum of healthcare organizations, including general and specialized hospitals, community health centers, township clinics, physical examination facilities, and disease prevention and control agencies. Supporting its extensive operations, Dian Diagnostics manages a global network of 40 advanced chain laboratories. Beyond its core diagnostic offerings, the company is also deeply involved in the research, development, and manufacturing of in vitro diagnostic reagents, along with associated equipment and consumables. Furthermore, it plays a crucial role in the medical supply chain, facilitating the provision of various products such as medical equipment, pharmaceuticals, clinical samples, biological products, finished blood products, live animals, chemical compounds, and diagnostic reagents. Dian Diagnostics also specializes in comprehensive cold chain logistics, which includes transportation, warehousing, product sales, and technical support services for temperature-sensitive medical goods. Founded in 2001, the company is headquartered in Hangzhou, China. It adopted its current name, Dian Diagnostics Group Co.,Ltd., in November 2017, having previously operated as Zhejiang DIAN Diagnostics Co., Ltd.
IPO date
Jul 19, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT